Healthcare · Pharmaceuticals & Biotechnology
Neuland Laboratories Limited is an Indian publicly listed contract development and manufacturing organization (CDMO) headquartered in Hyderabad. Founded in 1984, the company produces active pharmaceutical ingredients (APIs), advanced intermediates, and peptide APIs. Its shares are traded on the Bombay Stock Exchange and the National Stock Exchange.
Source: Wikipedia
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 2,053† | — | 1,571† | 1,201† | 956† |
| Net profit | 363 | 259 | 300 | 163 | 64† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Davuluri Rama Mohan Rao | Executive Director | June 30, 2026 |
| Davuluri Saharsh Rao | Executive Director | June 30, 2026 |
| Davuluri Sucheth Rao | Executive Director | June 30, 2026 |
| Homi Rustam Khusrokhan | Independent Director | June 30, 2026 |
| Pallavi Joshi Bhakru | Independent Director | June 30, 2026 |
| Prasad Raghava Menon | Independent Director | June 30, 2026 |
| Ravi Shankar Gopinath | Independent Director | June 30, 2026 |
| Sugata Sircar | Independent Director | June 30, 2026 |
| Mauricio Futran | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
